Intervet appoints Malte Greune as a member of the company's Executive Committee
15 November 2006
Intervet, Akzo Nobel’s veterinary pharma business, announces that Malte Greune (41) has been appointed as a member of Intervet’s Executive Committee. Malte Greune will succeed Joost Helsen in the function of Vice President Manufacturing and Logistics.
After finishing his study of Business Administration at the Clark University (USA) and ‘Diplom-Kaufmann’ at the University of Trier (Germany), Malte Greune received his doctoral degree from the University of Cologne. He received a number of awards for his achievements, among other things a ‘DAAD-Scholarship’ (USA) and was supported by the ‘Studienstiftung des Deutschen Volkes’ (German National Merit Foundation).In 1995 he started his carrier at Hoechst AG in Frankfurt, Germany. After a successful career in different management positions at Hoechst AG and Hoechst Roussel Vet (HR Vet) in Munich, he became Director Pharma Manufacturing/Strategic Procurement in Munich after Intervet acquired HRVet. In 2002 Malte Greune was promoted to Director Global Manufacturing Pharma and Biologicals in Boxmeer, the Netherlands.
Ruurd Stolp, President, Intervet, said: “I am delighted to welcome Malte Greune in our Executive Team. His experience in manufacturing and logistics is an asset for the company. He is excellently suited to further optimize our operational performance.”
- end -
Note for the editor
Intervet, a business unit of Akzo Nobel, based in Boxmeer, the Netherlands, with sales of EUR 1,094 million in 2005, is dedicated to research and development, production and marketing of innovative animal health products. Intervet's product range for use in livestock, companion animals, poultry and fish includes vaccines, antiparasitics, anti-infectives, endocrine products and other pharmaceutical specialties. Intervet operates globally with its own marketing organizations. The company currently employs around 5,000 people.
Internet: www.intervet.com
Akzo Nobel is a Global Fortune 500 company and is listed on both the Euronext Amsterdam and NASDAQ stock exchanges. It is also included on the Dow Jones Sustainability Indexes and FTSE4Good Index. Based in the Netherlands, we are a multicultural organization serving customers throughout the world with human and animal healthcare products, coatings, and chemicals. We employ more than 62,000 people and conduct our activities in four segments − human and animal health, coatings and chemicals − subdivided into 13 business units, with operating subsidiaries in more than 80 countries. Consolidated revenues for 2005 totaled EUR 13.0 billion. The financial results for the full year will be published on February 15, 2007.
Internet: www.akzonobel.com
Not for publication – for more information
Suzanne Hendriksen Tel: +31 (0)485 58 7893
Media Relations Officer Fax: +31 (0)485 58 5392
Intervet International bv suzanne.hendriksen@intervet.com
